MAP Pharmaceuticals, Inc.: key financial figures for fiscal year 2011 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2011)
- $23.1M
- Net Income/Loss (FY2011)
- -$32.9M
- Total Assets (FY2011)
- $107.3M
- Total Equity (FY2011)
- $39.6M
- Cash Flows from Operating Activities (FY2011)
- $29.7M
Source: MAP Pharmaceuticals, Inc. 10-K filing (FY2011). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
